FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569361914> ?p ?o ?g. }

• W1569361914 endingPage "636" @default.
• W1569361914 startingPage "630" @default.
• W1569361914 abstract "What's known on the subject? and What does the study add? Although many tests for identifying patients with new or recurrent bladder cancer have been used, a reliable method has yet to be established. Recently, increasing attention has focused on the role of survivin in bladder cancer detection. Because urine survivin tests have better sensitivity than cytology, urine survivin could potentially replace routine cytology and might be used as an adjunct method for cystoscopy. However, the clinical utility of urine survivin as a bladder tumour marker identified in the present study remains to be elucidated. To determine the clinical utility of urine survivin as a bladder tumour marker we systematically reviewed the available evidence. A comprehensive literature review was performed, from August 1997 to March 2011, using three search engines in English including PubMed, Cochrane Library, and SCOPUS. Two reviewers independently evaluated both trial eligibility and methodological quality and data extraction. We included studies that evaluated urine survivin, used cystoscopy and/or histopathology as the reference standard, and allowed the construction of a 2 × 2 contingency table. Bivariate random effect meta‐analyses were used to calculate the summary estimated of sensitivity and specificity and to construct a summary receiver‐operating characteristics curve of urine survivin tests. In all, 14 studies were included in the present review; two studies had two subsets of data. There were 2051 subjects, including 1038 in the case group and 1013 in the control group, and heterogeneity was present among diagnostic studies. The pooled sensitivity and specificity for urine survivin tests were 0.772 (95% confidence interval [CI] 0.745–0.797) and 0.918 (95% CI 0.899–0.934), respectively. The area under the curve of urine survivin tests was 0.9392. When a subgroup analysis with six studies was performed, urine survivin tests had better sensitivity than cytology, but did not match cytology for specificity. The clinical utility of urine survivin as a bladder tumour marker identified in the present study remains to be elucidated." @default.
• W1569361914 created "2016-06-24" @default.
• W1569361914 creator A5016904761 @default.
• W1569361914 creator A5044181467 @default.
• W1569361914 creator A5048604566 @default.
• W1569361914 creator A5052829104 @default.
• W1569361914 date "2012-02-21" @default.
• W1569361914 modified "2023-10-18" @default.
• W1569361914 title "Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review" @default.
• W1569361914 cites W117586056 @default.
• W1569361914 cites W1977602802 @default.
• W1569361914 cites W1990338523 @default.
• W1569361914 cites W1991810077 @default.
• W1569361914 cites W1997194058 @default.
• W1569361914 cites W2002045993 @default.
• W1569361914 cites W2003740803 @default.
• W1569361914 cites W2011166493 @default.
• W1569361914 cites W2014448379 @default.
• W1569361914 cites W2018214525 @default.
• W1569361914 cites W2026138983 @default.
• W1569361914 cites W2031977829 @default.
• W1569361914 cites W2035523654 @default.
• W1569361914 cites W2040386134 @default.
• W1569361914 cites W2050467307 @default.
• W1569361914 cites W2072248652 @default.
• W1569361914 cites W2085907805 @default.
• W1569361914 cites W2115811792 @default.
• W1569361914 cites W2116386682 @default.
• W1569361914 cites W2126930838 @default.
• W1569361914 cites W2128580887 @default.
• W1569361914 cites W2131778120 @default.
• W1569361914 cites W2146500821 @default.
• W1569361914 cites W2147493587 @default.
• W1569361914 cites W2151287133 @default.
• W1569361914 cites W2155913947 @default.
• W1569361914 cites W2158734599 @default.
• W1569361914 cites W2169160087 @default.
• W1569361914 cites W312523482 @default.
• W1569361914 doi "https://doi.org/10.1111/j.1464-410x.2011.10884.x" @default.
• W1569361914 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22353238" @default.
• W1569361914 hasPublicationYear "2012" @default.
• W1569361914 type Work @default.
• W1569361914 sameAs 1569361914 @default.
• W1569361914 citedByCount "43" @default.
• W1569361914 countsByYear W15693619142013 @default.
• W1569361914 countsByYear W15693619142014 @default.
• W1569361914 countsByYear W15693619142015 @default.
• W1569361914 countsByYear W15693619142016 @default.
• W1569361914 countsByYear W15693619142017 @default.
• W1569361914 countsByYear W15693619142018 @default.
• W1569361914 countsByYear W15693619142019 @default.
• W1569361914 countsByYear W15693619142020 @default.
• W1569361914 countsByYear W15693619142021 @default.
• W1569361914 countsByYear W15693619142022 @default.
• W1569361914 countsByYear W15693619142023 @default.
• W1569361914 crossrefType "journal-article" @default.
• W1569361914 hasAuthorship W1569361914A5016904761 @default.
• W1569361914 hasAuthorship W1569361914A5044181467 @default.
• W1569361914 hasAuthorship W1569361914A5048604566 @default.
• W1569361914 hasAuthorship W1569361914A5052829104 @default.
• W1569361914 hasConcept C121608353 @default.
• W1569361914 hasConcept C126322002 @default.
• W1569361914 hasConcept C126894567 @default.
• W1569361914 hasConcept C143998085 @default.
• W1569361914 hasConcept C2775975398 @default.
• W1569361914 hasConcept C2776478404 @default.
• W1569361914 hasConcept C2777548846 @default.
• W1569361914 hasConcept C2778769751 @default.
• W1569361914 hasConcept C2779225474 @default.
• W1569361914 hasConcept C2780026642 @default.
• W1569361914 hasConcept C2780352672 @default.
• W1569361914 hasConcept C71924100 @default.
• W1569361914 hasConcept C77411442 @default.
• W1569361914 hasConcept C95190672 @default.
• W1569361914 hasConceptScore W1569361914C121608353 @default.
• W1569361914 hasConceptScore W1569361914C126322002 @default.
• W1569361914 hasConceptScore W1569361914C126894567 @default.
• W1569361914 hasConceptScore W1569361914C143998085 @default.
• W1569361914 hasConceptScore W1569361914C2775975398 @default.
• W1569361914 hasConceptScore W1569361914C2776478404 @default.
• W1569361914 hasConceptScore W1569361914C2777548846 @default.
• W1569361914 hasConceptScore W1569361914C2778769751 @default.
• W1569361914 hasConceptScore W1569361914C2779225474 @default.
• W1569361914 hasConceptScore W1569361914C2780026642 @default.
• W1569361914 hasConceptScore W1569361914C2780352672 @default.
• W1569361914 hasConceptScore W1569361914C71924100 @default.
• W1569361914 hasConceptScore W1569361914C77411442 @default.
• W1569361914 hasConceptScore W1569361914C95190672 @default.
• W1569361914 hasIssue "5" @default.
• W1569361914 hasLocation W15693619141 @default.
• W1569361914 hasLocation W15693619142 @default.
• W1569361914 hasOpenAccess W1569361914 @default.
• W1569361914 hasPrimaryLocation W15693619141 @default.
• W1569361914 hasRelatedWork W1981441076 @default.
• W1569361914 hasRelatedWork W1988013651 @default.
• W1569361914 hasRelatedWork W2029203446 @default.
• W1569361914 hasRelatedWork W2037888279 @default.
• W1569361914 hasRelatedWork W2073235429 @default.

• next